Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001686530-21-000005
Filing Date
2021-06-29
Accepted
2021-06-29 14:30:42
Documents
1
Period of Report
2021-06-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2175
  Complete submission text file 0001686530-21-000005.txt   3640
Mailing Address C/O COMPASS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 601 BOSTON MA 02135
Business Address
Toledano Miranda Jayne (Reporting) CIK: 0001686530 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39696 | Film No.: 211057446

Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)